M. Aicher

发表

Development of selective MELK kinase inhibitors for breast cancer treatment

D. Ito, P. Zhu, N. Larsen, 2016 .

Abstract 2932: SF3B1 mutations induce aberrant mRNA splicing in cancer and confer sensitivity to spliceosome inhibition

M. Warmuth, K. Kunii, J. Feala, 2014 .